Free Trial Information
BioCentury | Oct 4, 2018
Distillery Techniques

Drug delivery

...online Sept. 14, 2018 doi:10.1021/jacs.8b07086 CONTACT: Fiorenzo Vetrone, University of Quebec, Quebec City, Quebec email: vetrone@emt.inrs.ca Jaime De Leon University of Quebec Cancer...
Read More
BioCentury | May 28, 2007
Company News

Biophage scientific advisory board update

...Inflammation, Veterinary Appointed: Maximilien Arella, professor of virology at the Institut Armand Frappier at the University of Quebec WIR...
Read More
BioCentury | Sep 15, 2003
Company News

ProtKinetix scientific advisory board update

...PKTX), Vancouver, B.C. Business: Cancer Appointed: Maximilien Arella, professor of microbiology and biotechnology at the University of Quebec WIR...
Read More
BioCentury | Dec 23, 1996
Company News

Labopharm, University of Quebec deal

...using the technology. The university is eligible to receive royalties. Labopharm Inc. (TSE:DDS), Sainte-Therese, Quebec University of Quebec...
Read More
BioCentury | Jan 23, 1995
Company News

Labopharm deal

Labopharm (Ste-Thérèse, Québec) acquired from the University of Québec and the University of Montréal rights to a drug delivery technology derived from corn starch. The product, cross-linked amylose tradenamed Contramid, is a hydrophilic matrix manufactured...
Read More
BioCentury | Mar 14, 1994
Company News

Neoprobe deal

...received an exclusive license to the monoclonal antibody BCD-F9 from the Institut Armand-Frappier at the University of Quebec...
Read More
Items per page:
1 - 6 of 6
BioCentury | Oct 4, 2018
Distillery Techniques

Drug delivery

...online Sept. 14, 2018 doi:10.1021/jacs.8b07086 CONTACT: Fiorenzo Vetrone, University of Quebec, Quebec City, Quebec email: vetrone@emt.inrs.ca Jaime De Leon University of Quebec Cancer...
Read More
BioCentury | May 28, 2007
Company News

Biophage scientific advisory board update

...Inflammation, Veterinary Appointed: Maximilien Arella, professor of virology at the Institut Armand Frappier at the University of Quebec WIR...
Read More
BioCentury | Sep 15, 2003
Company News

ProtKinetix scientific advisory board update

...PKTX), Vancouver, B.C. Business: Cancer Appointed: Maximilien Arella, professor of microbiology and biotechnology at the University of Quebec WIR...
Read More
BioCentury | Dec 23, 1996
Company News

Labopharm, University of Quebec deal

...using the technology. The university is eligible to receive royalties. Labopharm Inc. (TSE:DDS), Sainte-Therese, Quebec University of Quebec...
Read More
BioCentury | Jan 23, 1995
Company News

Labopharm deal

Labopharm (Ste-Thérèse, Québec) acquired from the University of Québec and the University of Montréal rights to a drug delivery technology derived from corn starch. The product, cross-linked amylose tradenamed Contramid, is a hydrophilic matrix manufactured...
Read More
BioCentury | Mar 14, 1994
Company News

Neoprobe deal

...received an exclusive license to the monoclonal antibody BCD-F9 from the Institut Armand-Frappier at the University of Quebec...
Read More
Items per page:
1 - 6 of 6